KY
Kyverna Therapeutics, Inc.
KYTX · NASDAQ
$6.90 -1.71% (-$0.12)
1M -18.82%
Market Cap $419.5M
P/E Ratio -
Div. Yield -
ROE 81.91%
Piotroski F-Score Weak
1/9Valuation
74 /100
Cheap P/B 2.53x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 70.73%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 80.05%
ROE 81.91%
ROA 69.44%
Debt
69 /100
Low Debt/Equity 0.20x
Current ratio 9.06x
Int. coverage -85.23x
Stability
1 /100
Unstable Beta 1.99x
EPS volatility 1,922,544.84%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre KYTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Warner Biddle
Employees
149
Headquarters
Emeryville
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report